| Summary: | Objective To investigate the molecular mechanism of interleukin-17 in the development of gastric cancer through NF-κB signaling pathway. Methods Thirty patients with gastric cancer in Wuwei Cancer Hospital of Gansu province and 30 control individuals who had physical examination in the hospital at the same time were selected. The expression of IL-17,IL-6 and IL-8 in serum of patients with gastric cancer and control was detected by ELISA.The pathological changes of gastric cancer were observed by microscopy with HE staining; Immunohisto-chemistry method was used to detect the expression of IL-17, NF-κB p65, IKK-β and IL-6 in gastric cancer tissues, adjacent tissues and gastric tissues far from cancer tissues.The expressions of IL-17, NF-κB p65, pNF-κB p65, IKK-β and IL-6 in gastric cancer tissues, adjacent tissues and gastric tissues far from cancer tissues were detected by Western blot. Results IL-17, IL-6 and IL-8 were up-regulated in serum of gastric cancer patients compared with healthy controls group(P＜0.05). The expressions of IL-17, NF-κB p65, IKK-β and IL-6 in gastric cancer tissues were significantly higher than that in normal and adjacent groups (P＜0.05). The expressions of IL-17, NF-κB p65, pNF-κB p65, IKK-β and IL-6 were increased in gastric cancer tissues compared with normal gastric tissue (P＜0.05); the expressions of pNF-κB p65, IKK-β and IL-6 increased in peri-cancer tissues compared with normal gastric tissue (P＜0.05).The expressions of IL-17, NF-κB p65, pNF-κB p65, IKK-β and IL-6 were increased in gastric cancer tissues compared with adjacent tissues(P＜0.05). Conclusions IL-17 can stimulate IL-6 to function in regulation of gastric cancer and promote the development of gastric cancer through the NF-κB p65 signaling pathway.This result may provide new insights into the pathogenesis of gastric cancer and suggests that IL-17 may be a potential target of gastric cancer treatment.
|
|---|